| Literature DB >> 29401723 |
Yonggang Wang1,2,3, Xu Wang4,5, Mingwei Li6,7, Jing Dong8,9, Changhong Sun10,11, Guanyi Chen12.
Abstract
This study focuses on the application of combining membrane bioreactor (MBR) treatment with reverse osmosis (RO) or nanofiltration (NF) membrane treatment for removal of pharmaceuticals and personal care products (PPCPs) in municipal wastewater. Twenty-seven PPCPs were measured in real influent with lowest average concentration being trimethoprim (7.12 ng/L) and the highest being caffeine (18.4 ng/L). The results suggest that the MBR system effectively removes the PPCPs with an efficiency of between 41.08% and 95.41%, and that the integrated membrane systems, MBR-RO/NF, can achieve even higher removal rates of above 95% for most of them. The results also suggest that, due to the differences in removal mechanisms of NF/RO membrane, differences of removal rates exist. In this study, the combination of MBR-NF resulted in the removal of 13 compounds to below detection limits and MBR-RO achieved even better results with removal of 20 compounds to below detection limits.Entities:
Keywords: PPCPs; membrane bioreactor; nanofiltration; removal mechanisms; reverse osmosis; wastewater
Mesh:
Substances:
Year: 2018 PMID: 29401723 PMCID: PMC5858338 DOI: 10.3390/ijerph15020269
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Schematic representation of the MBR-RO/NF pilot plant showing different compartments, flow directions, main instruments and equipment.
Properties of three membrane modules.
| Membrane Component | Texture | Type | Rejection (%) a | Effective Area (m2) | General Operation Pressure (KPa) | General Operation Flux (LMH) | |
|---|---|---|---|---|---|---|---|
| Average | Minimum | ||||||
| RO | PA b | Duraslick RO 2540 | 98.6% (NaCl) | 97% (NaCl) | 2.5 | 1379 | 15–25 |
| NF | PA b | Duraslick NF-2540 | 98.6% (MgSO4) | 96% (MgSO4) | 2.2 | 690 | 15–25 |
| MBR | PVDF c + PET d | PEIER-B-80 | - | - | 0.8 | - | - |
a taking test after running 24 h, the average rejection of single membrane might be −15% ~ +25%; b PA: Polyamide; c PVDF: Polyvinylidene fluoride; d PET: Polyethylene terephthalate.
Physicochemical properties of the selected compounds.
| Analytes | MW (g/mol) | Formula | CAS Number | Log | pKa * | Solubility * (mg/L) | Classification |
|---|---|---|---|---|---|---|---|
| Caffeine | 194.19 | C8H10N4O2 | 58-08-2 | −0.07 | 6.1; 0.73 | 2.16 × 104 | Stimulant |
| Atenolol | 266.34 | C14H22N2O3 | 29122-68-7 | 0.16 | 13.88; 9.16 | N/A | β--blocker |
| Metoprolol | 267.36 | C15H25NO3 | 51384-51-1 | 1.88 | 9.68 | N/A | β--blocker |
| Amoxicillin | 365.4 | C16H19N3O5S | 26787-78-0 | 0.91 | N/A | N/A | β-lactams Antibiotic |
| Trimethoprim | 290.32 | C14H18N4O3 | 738-70-5 | 0.87 | 6.3; 4.0; 7.2 | 12100 | Pyrimethamine antibiotic |
| Sulfadimidine | 278.33 | C12H14N4O2S | 57-68-1 | 0.89 | 7.4 | 1500 | Sulfonamides antibiotics |
| Sulfamethoxazole | 253.27 | C10H11N3O3S | 723-46-6 | 0.48 | 2.1; 5.81; 1.39 | 610 | Sulfonamides antibiotics |
| Norfloxacin | 319.33 | C16H18FN3O3 | 70458-96-7 | −1.03 | N/A | N/A | Fluoroquinolone antibiotics |
| Ofloxacin | 361.37 | C18H20FN3O4 | 82419-36-1 | −0.39 | N/A | N/A | Fluoroquinolone antibiotics |
| Ciprofloxacin | 331.34 | C17H18FN3O3 | 85721-33-1 | 0.28 | N/A | 3.0 × 104 | Fluoroquinolone antibiotics |
| Lomefloxacin | 351.35 | C17H19F2N3O3 | 98079-51-7 | −0.23 | N/A | N/A | Fluoroquinolone antibiotics |
| Enrofloxacin | 359.4 | C19H22FN3O3 | 93106-60-6 | −0.63 | N/A | N/A | Fluoroquinolone antibiotics |
| Oxytetracycline | 460.43 | C22H24N2O9 | 79-57-2 | −0.9 | 3.27 | N/A | Tetracycline antibiotics |
| Tetracycline | 444.44 | C22H24N2O8 | 60-54-8 | −1.37 | 3.30 | N/A | Tetracycline antibiotics |
| Chlortetracycline | 478.88 | C22H23ClN2O8 | 57-62-5 | −0.9 | 3.30 | N/A | Tetracycline antibiotics |
| Doxycycline | 444.44 | C22H24N2O8 | 564-25-0 | −0.02 | 3.30 | N/A | Tetracycline antibiotics |
| Clarithromycin | 747.95 | C38H69NO13 | 81103-11-9 | 3.16 | 8.9 | 0.33 | Macrolide antibiotics |
| Erythromycin-H2O | 715.916 | C37H65NO12 | 23893-13-2 | 3.06 | 8.9 | 1.44 | Macrolide antibiotics |
| Roxithromycin | 837.05 | C41H76N2O15 | 80214-83-1 | 1.7 | 8.8 | 0.019 | Macrolide antibiotics |
| Azithromycin | 748.98 | C38H72N2O12 | 83905-01-5 | 4.02 | 8.8 | N/A | Macrolide antibiotics |
| Carbamazpine | 236.27 | C15H12N2O | 298-46-4 | 2.25 | 13.90; −0.49 | 112 | Antiepilepti |
| Benzhabeite | 361.82 | C19H20ClNO4 | 41859-67-0 | N/A | N/A | N/A | Antihypercholesterolemic |
| Bisphenol A | 228.29 | C15H16O2 | 80-05-7 | 3.32 | 9.73 | 120 | Plasticizer |
| Nonylphenol | 220.35 | C15H24O | 25154-52-3 | 5.76 | 10.14 | N/A | Plasticizer |
| Estrone | 270.37 | C18H22O2 | 53-16-7 | 3.13 | 10.25; 10.5 | N/A | Hormone |
| 17β-Estradiol | 272.38 | C18H24O2 | 50-28-2 | 4.01 | 10.27; 10.4 | 3.6 | Hormone |
| Estriol | 288.38 | C18H24O3 | 50-27-1 | 2.45 | 10.25; >15 | 444 | Hormone |
* Physico-chemical information was obtained from [19,25,26,27]. N/A: Not applicable.
Concentration ranges and mean values (n = 6) of target contaminants in wastewater influent and limit of quantitation (LOQ) with standard deviation in parentheses (n = 6).
| Compounds | LOQ (ng/L) | Range (μg /L) | Mean (μg /L) |
|---|---|---|---|
| Caffeine | 10.6 (4.1) | 8.53–33.7 | 18.4 |
| Atenolol | 8.54 (3.32) | 0.012–0.409 | 0.166 |
| Metoprolol | 9.85 (4.56) | 0.437–3.21 | 1.73 |
| Amoxicillin | 6.11 (4.07) | 0.008–0.035 | 0.02 |
| Trimethoprim | 11.2 (7.35) | n.d. −0.023 | 0.007 |
| Sulfadimidine | 4.75 (2.32) | 0.005–0.131 | 0.059 |
| Sulfamethoxazole | 6.83 (3.22) | 0.012–0.092 | 0.037 |
| Norfloxacin | 10.63 (6.12) | 0.014–0.226 | 0.106 |
| Ofloxacin | 14.46 (10.32) | 0.1–0.912 | 0.560 |
| Ciprofloxacin | 3.65 (1.55) | n.d. −0.089 | 0.034 |
| Lomefloxacin | 2.12(1.46) | n.d. −0.0388 | 0.01 |
| Enrofloxacin | 3.56 (1.47) | n.d. −0.008 | 0.004 |
| Oxytetracycline | 2.66 (1.75) | 0.009–0.035 | 0.018 |
| Tetracycline | 2.32 (1.02) | 0.003–0.008 | 0.023 |
| Chlortetracycline | 4.11 (1.36) | n.d. −0.022 | 0.008 |
| Doxycycline | 2.33 (1.21) | n.d. −0.08 | 0.018 |
| Clarithromycin | 35.11 (15.88) | n.d. −1.26 | 0.368 |
| Erythromycin-H2O | 43.4 (45.9) | n.d. −0.082 | 0.020 |
| Roxithromycin | 35.3 (15.44) | n.d. −0.253 | 0.079 |
| Azithromycin | 23.12 (4.98) | 0.047–4.42 | 1.41 |
| Carbamazpine | 3.13 (1.78) | n.d. −0.032 | 0.014 |
| Benzhabeite | 20.3 (8.65) | 0.022–0.151 | 0.074 |
| Bisphenol A | 16.46 (6.21) | 0.3–1.52 | 0.833 |
| Nonylphenol | 15.2 (10.6) | 0.126–0.873 | 0.421 |
| Estrone | 7.65 (3.32) | 0.078–0.158 | 0.106 |
| 17β-Estradiol | 10.1 (4.40) | 0.011–0.054 | 0.030 |
| Estriol | 8.32 (4.67) | 0.042–0.162 | 0.092 |
n.d.: not detectable (below the LOQ).
Figure 2Removal efficiency of the model contaminants and their corresponding hydrophobicity (LogKow) by MBR treatment.
Figure 3The chemical structure of Estrone/17β-Estradiol/Estriol.
Figure 4Overall removal efficiency of the selected contaminants by MBR-RO system.
Figure 5Overall removal efficiency of the selected contaminants by MBR-NF system.